Editor's Note: Green and red arrows refer to intraday stock price movement.
NEW YORK (
STOCK COMMENTS / EPS CHANGES
added to Top Picks List at FBR Capital Markets. Company can continue to deliver solid growth in the current environment.
price target boosted at Citi to $46 from $41. CVS has been awarded a three-year contract to provide integrated PBM services for Federal Employee Program, Citigroup said.
Johnson & Johnson
price target higher at Citi by a dollar to $71. JNJ's overhaul of its Pharma division 10 years ago hit its stride this year, seeing fundamental turn, Citigroup said. Maintain Buy rating.
estimates, target upped at Benchmark. MCO estimates were boosted through 2012, Benchmark said. Company should benefit from better investment-grade issuance. Overweight rating and new $45 price target.
numbers boosted at Jefferies. Shares of MGM now seen reaching $19, according to Jefferies. Estimates also upped, given better trends in Macau and Singapore. Buy rating.
cut from Top Picks List at FBR Capital Markets. Company lost $3 billion annual contract to CVS. Target also lowered to $71.
numbers increased at Goldman. NEE estimates were raised through 2014. Company should see higher earnings at its regulated assets. Neutral rating and new $58 price target.
estimates, target raised at Goldman. Shares of VALE now seen reaching $44. Estimates also increased, as iron ore prices should benefit from lower supply. Buy rating.
End of report.
This article was written by a staff member of TheStreet.